The FDA's War on Peptides: A Complete 2024-2026 Enforcement Timeline
Complete timeline of FDA and ITC enforcement actions against peptide vendors from 2024-2026. Warning letters, exclusion orders, and the BPC-157 ban.
Evidence: well established
Analysis & Intelligence
Evidence-based analysis, vendor accountability, and honest guidance in a market flooded with marketing claims.
Infiniwell Review: When Marketing Outruns the Science
Independent deep dive into Infiniwell's SNAC-enhanced BPC-157 products. We examine the technology claims, the missing studies, and what consumers should know.
Evidence: expert analysis
What's Actually in Your Peptides? The Quality Crisis Nobody Talks About
Analysis of independent testing data revealing alarming quality failures in grey-market peptides. What Finnrick, Janoshik, and other labs have found.
Evidence: expert analysis
Getting Started with Peptides: The Complete Beginner's Guide
New to peptides? Our beginner's guide covers what peptides are, how to evaluate vendors, safety considerations, and what to know first.
Evidence: expert analysis
Oral Peptides: What Actually Works? A Bioavailability Deep Dive
Learn which peptides have genuine oral bioavailability and which don't. Science-based guide to absorption technologies like SNAC and liposomes.
Evidence: expert analysis
PDA vs. BPC-157: The Same Peptide in a Different Wrapper
Analysis of Pentadeca Arginate (PDA) claims: the patent, the chemistry, and the missing evidence behind '99% bioavailability' marketing.
Evidence: expert analysis
The FDA's Peptide Crackdown: A Complete Timeline
Timeline of FDA enforcement actions against peptide vendors from 2023-2026: warning letters, criminal cases, and regulatory changes.
Evidence: well established
The Semaglutide Crisis: When the Only Proven Peptide Becomes the Most Dangerous
How semaglutide went from pharmaceutical breakthrough to public health crisis. The compounding controversy, counterfeit risks, and what consumers need to know.
Evidence: well established
TB-500 Is Not Thymosin Beta-4: The Fragment Problem
Critical analysis of TB-500 vs. Thymosin Beta-4. The research uses one molecule; the market sells another. We examine what the evidence actually supports.
Evidence: expert analysis
Oral BPC-157 Bioavailability: What the Science Actually Shows
An evidence-based analysis of oral BPC-157 bioavailability claims. We examine what the research actually shows versus what vendors tell you.
Evidence: animal only
50+ FDA Warning Letters in One Month: What September 2025 Means for You
Analysis of the FDA's September 2025 enforcement wave: 50+ warning letters to peptide and GLP-1 compounders in a single month.
Evidence: expert analysis
How to Read a Peptide Certificate of Analysis (And Spot a Fake)
Learn to evaluate peptide COAs: what each test means, red flags for fake documentation, and which labs are considered credible.
Evidence: expert analysis